Features | Partner Sites | Information | LinkXpress
Sign In
Agfa Healthcare

Heart Scans Only Useful in Specific Situations When Statins Are Prescribed

By Medimaging International staff writers
Posted on 01 Apr 2014
Image: A computed tomography (CT) scan of a healthy heart shows the coronary artery running down the front. A scan showing calcium buildup in the artery could trigger treatment (Photo courtesy of Vassilios Raptopoulo).
Image: A computed tomography (CT) scan of a healthy heart shows the coronary artery running down the front. A scan showing calcium buildup in the artery could trigger treatment (Photo courtesy of Vassilios Raptopoulo).
New research has revealed that with the existence of inexpensive statin therapy, which lowers cholesterol and is readily available, it is not necessary to perform a heart computed tomography (CT) imaging scan to measure how much plaque has accumulated in a patient’s coronary arteries, when patients have been taking statins.

Researchers from the University of California San Francisco (UCSF; USA) designed a statistical model to forecast whether it was practical to do the scan, using data from the Multi-Ethnic Study of Atherosclerosis (MESA) and other sources. They modeled the effects of statin therapy in 10,000 55-year-old women with high cholesterol and a 10-year risk of coronary heart disease of 7.5%. The model predicted that prescribing statins to all of them would prevent 32 heart attacks, cause 70 instances of statin-induced muscle disease, and add 1,108 years to their cumulative life expectancy.

Then, the investigators looked at how a coronary artery calcium (CAC) test could be used to target statin therapy only in those women the test showed were at heightened risk of coronary heart disease. They found that this strategy would save money on statin costs and expose fewer women to side effects from statins but would not prevent as many heart attacks. Moreover, the test itself exposes the women to a small risk of radiation-induced cancer and costs about USD 200 to USD 400 per scan.

The researchers concluded that as long as the price of a statin remained low— USD 0.13 a pill—and did not reduce quality of life for patients, it was not cost-effective to perform a CAC test. But if the price of the pill were more costly—USD 1 or more—or if taking them reduced patients’ quality of life, then it did make sense to use the CAC test.

The result is somewhat surprising, given all the evidence that has accumulated over the last decade that the test strongly predicts heart attacks, said the lead author, Mark Pletcher, MD, MPH, an associate professor of epidemiology and biostatistics, and medicine, at UCSF. The study was published online March 11, 2014, in the journal Circulation: Cardiovascular Quality Outcomes.

Traditional prediction models, such as the Framingham-based risk equations, work imperfectly, and clinicians have long tried to find better ways to figure out which patients would benefit most from taking statins, which can cause side effects, such as decreased cognitive function, muscle aches, and cataracts.

“The prevailing wisdom is that if you have a test that predicts heart attacks, you should use it,” Dr. Pletcher said. “But even a test that is strongly predictive of future events, like a coronary artery calcium scan, does not itself improve outcomes. If it is used to keep some people off of statins that would otherwise take them, then fewer people will get protection from using statins, and more people will have heart attacks.”

The study integrated data from MESA and many other sources to create a cost-effectiveness model. The researchers tested whether changing the other model inputs made a difference, and it turned out that the only critical factors were the cost of statins and the degree to which they decreased quality of life for patients.

Related Links:

University of California San Francisco



view channel
Image: In a preterm infant’s brain, an MRI scan can reveal abnormalities that were undetected by previous methods. The scans on the left show normal gray matter, while those on the right show abnormal gray matter (Photo courtesy of Washington University in St. Louis).

MRI Tracks Infant Brain Growth in First Months of Life

For the first time, researchers have used magnetic resonance imaging (MRI) of the newborn brain to calculate the volume of multiple brain regions and to map out regional growth trajectories during the... Read more


view channel
Image: Fig. 1a and Fig. 1b depict the guided signals in the intact and fractured long bones, respectively. These images shows an (a) intact and (b) 1-mm width 100% depth fracture (Photo courtesy of Science China Press).

Quantitative Ultrasound Shown to Optimize Assessment of Long Bone Fracture

Research has revealed that mode conversion of ultrasonic-guided waves can quantitatively indicate the fracture degree of long cortical bone, which may provide a new way of evaluating long bone fracture... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.